Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3158686 | 1.00 | MAPT (0.36) | MAPTPTPN1IDO1TDO2 | |
| SCHEMBL3161230 | 1.00 | MAPT (0.36) | MAPTPTPN1IDO1TDO2 | |
| SCHEMBL14458060 | 0.81 | MAPT (0.36) | MAPTPTPN1IDO1TDO2 | |
| SCHEMBL14458061 | 0.81 | MAPT (0.36) | MAPTPTPN1IDO1TDO2 | |
| SCHEMBL4293411 | 0.76 | — | — | |
| SCHEMBL3659400 | 0.76 | MAPT (0.34) | MAPT | |
| SCHEMBL3659823 | 0.76 | MAPT (0.34) | MAPT | |
| SCHEMBL5605733 | 0.75 | IDO1 (0.33) | MAPTIDO1TDO2 | |
| SCHEMBL3162292 | 0.75 | IDO1 (0.33) | MAPTIDO1TDO2 | |
| SCHEMBL11223105 | 0.71 | MAPT (0.45) | MAPTPTPN1IDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018114733-A1 | PROCESS FOR THE PREPARATION OF STEREOISOMERIC PURE C9-ACETALS | BASF SE (DE) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018114732-A1 | PROCESS FOR PREPARING (4S)- OR (4R)-3,4-DIHYDROXY-2,6,6-TRIMETHYLCYCLOHEX-2-ENONE | BASF SE (DE) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018114732-A1 | PROCESS FOR PREPARING (4S)- OR (4R)-3,4-DIHYDROXY-2,6,6-TRIMETHYLCYCLOHEX-2-ENONE | BASF SE (DE) | 2018-06-28 | — | — | WO | disclosed |
| US-20100041922-A1 | METHOD FOR THE ENANTIOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-2-ENONE DERIVATIVES | BASF SE (DE) | 2010-02-18 | — | — | US | disclosed |
| US-20100041922-A1 | METHOD FOR THE ENANTIOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-2-ENONE DERIVATIVES | BASF SE (DE) | 2010-02-18 | — | — | US | disclosed |
| US-20100041922-A1 | METHOD FOR THE ENANTIOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-2-ENONE DERIVATIVES | BASF SE (DE) | 2010-02-18 | — | — | US | disclosed |
| EP-2142494-A1 | METHOD FOR THE ENANTIOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-2-ENONE DERIVATIVES | BASF SE (DE) | 2010-01-13 | — | — | EP | disclosed |
| WO-2008116714-A1 | METHOD FOR THE ENANTIOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-2-ENONE DERIVATIVES | BASF SE (DE) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008116714-A1 | METHOD FOR THE ENANTIOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-2-ENONE DERIVATIVES | BASF SE (DE) | 2008-10-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041922-A1 | METHOD FOR THE ENANTIOSELECTIVE PRODUCTION OF OPTICALLY ACTIVE 4-HYDROXY-2,6,6-TRIMETHYL-CYCLOHEX-2-ENONE DERIVATIVES | CYP8B1, CYP51A1, HSD3B1 | MAPT 4592/4885PTPN1 4879/4885IDO1 724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.